New studies have shown that ibogaine’s mechanism of action inhibits nicotinic acetylcholine receptors (nAChRs). Nicotinic acetylcholine receptors are involved in a variety of neurobiological processes, including releasing neurotransmitters which include dopamine, which might be intensely involved with the Mind’s reward and pleasure pathways. To be a Agenda I controlled substance, https://neilk307tsp3.estate-blog.com/profile